Reliability of KHQ and ICIQ-SF in Assessing Urinary Incontinence Effects in Polish Women

November 5, 2020 updated by: Katarzyna Skorupska, Medical University of Lublin

Reliability of The King's Health Questionnaire and the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form in Assessing Urinary Incontinence Effects in Polish Women

The aim of this study was to assess the psychometric properties of KHQ and ICIQ-SF in polish women.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Purpose The King's Health Questionnaire (KHQ) and the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form are widely used in clinical practice. The aim of this study was to assess the psychometric properties of KHQ and ICIQ-SF in polish women.

Methods One hundred fifty-five women with urinary incontinence (UI) aged between 19-82 years underwent urodynamic investigation and completed both KHQ and ICIQ-SF. To evaluate the factor structure and construct the validity of the KHQ and ICIQ, Principal Component Analysis (PCA) using VARIMAX rotation was conducted for all questionnaire items. PCA results were also confirmed by Spearman's correlations between KHQ and ICIQ items. Moreover, the internal consistency of the KHQ and ICIQ was estimated by way of Cronbach's alpha coefficient (α). Statistical analysis was performed using STATISTICA version 13.1 software (StatSoft, Poland), as well as open source R software (version 3.4.4).

Study Type

Observational

Enrollment (Actual)

155

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Poland
      • Lublin, Poland, 20-059
        • Katarzyna Skorupska

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 82 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

women age 18-82 years who declared symptoms of urinary incontinence

Description

Inclusion Criteria:

  • informed consent
  • patients with symptoms of urinary incontinence
  • age 18-82 years

Exclusion Criteria:

  • lack of consent
  • inability to understand the study protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
no urinary incontinence
patients without UI
Diagnostic test: King's Health Questionnaire
patients fulfilled questionnaire
Diagnostic test: the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
patients fulfilled ICIQ-SF questionnaire
stress urinary incontinence
patients with SUI
Diagnostic test: King's Health Questionnaire
patients fulfilled questionnaire
Diagnostic test: the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
patients fulfilled ICIQ-SF questionnaire
overactive bladder
patients with OAB
Diagnostic test: King's Health Questionnaire
patients fulfilled questionnaire
Diagnostic test: the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
patients fulfilled ICIQ-SF questionnaire
mix urinary incontinence
patients with MUI
Diagnostic test: King's Health Questionnaire
patients fulfilled questionnaire
Diagnostic test: the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
patients fulfilled ICIQ-SF questionnaire
Urge
patients with urge incontinence
Diagnostic test: King's Health Questionnaire
patients fulfilled questionnaire
Diagnostic test: the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
patients fulfilled ICIQ-SF questionnaire

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
psychometric properties of KHQ in polish women with urinary incontinence
Time Frame: 2017-2018
psychometric properties of KHQ
2017-2018
psychometric properties of ICIQ-SF in polish women with urinary incontinence
Time Frame: 2017-2018
psychometric properties of ICIQ-SF
2017-2018

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Medical University of Lublin

Investigators

  • Study Director: Tomasz Rechberger, Professor, Medical University of Lublin

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2017

Primary Completion (Actual)

December 30, 2018

Study Completion (Actual)

January 10, 2019

Study Registration Dates

First Submitted

November 2, 2020

First Submitted That Met QC Criteria

November 5, 2020

First Posted (Actual)

November 6, 2020

Study Record Updates

Last Update Posted (Actual)

November 6, 2020

Last Update Submitted That Met QC Criteria

November 5, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2\2020

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overactive Bladder

Clinical Trials on King's Health Questionnaire

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe